Robert Espy
Acute Care · Dothan, ALNPI 1205130499
Payments from drug & device makers
Across 272 payments — averaging $14.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$510
- AbbVie$369
- Takeda Pharmaceuticals U.S.A., Inc.$323
- Johnson & Johnson$304
- Novo Nordisk$299
- Nevro Corp.$197
- plus $2K from 30 others
What the payments were for
- Food & beverage$4,011100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 28 | $510 |
| AbbVie | 24 | $369 |
| Takeda Pharmaceuticals U.S.A., Inc. | 20 | $323 |
| Johnson & Johnson | 30 | $304 |
| Novo Nordisk | 34 | $299 |
| Nevro Corp. | 9 | $197 |
| Lilly USA, LLC | 21 | $191 |
| Bayer | 11 | $183 |
| GSK | 10 | $174 |
| Amgen | 11 | $165 |
| Otsuka America Pharmaceutical, Inc. | 8 | $130 |
| Boehringer Ingelheim | 6 | $118 |
| Abbott | 8 | $110 |
| Amarin Pharma, Inc. | 6 | $107 |
| Novartis | 7 | $101 |
| Biohaven Pharmaceutical Holding Company Ltd. | 5 | $96 |
| Corium, LLC | 4 | $87 |
| Corcept Therapeutics | 5 | $85 |
| Medtronic | 1 | $59 |
| Dexcom, Inc. | 3 | $44 |
| Inspire Medical Systems, Inc. | 2 | $42 |
| Xeris Pharmaceuticals, Inc. | 2 | $42 |
| Astellas Pharma US Inc | 2 | $33 |
| Lundbeck LLC | 2 | $33 |
| Biohaven Pharmaceuticals, Inc. | 2 | $30 |
| Scilex Pharmaceuticals Inc. | 1 | $24 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $23 |
| UCB, Inc. | 1 | $23 |
| Axsome Therapeutics, Inc. | 1 | $19 |
| Pfizer | 1 | $17 |
| Sumitomo Pharma America, Inc. | 1 | $14 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $14 |
| Exact Sciences | 1 | $14 |
| Avanir Pharmaceuticals, Inc. | 1 | $13 |
| E.r. Squibb & Sons, L.L.C. | 1 | $11 |
| Phathom Pharmaceuticals, Inc. | 1 | $7 |
How this compares
$4,011 in reported general payments places this provider in the 85th percentile of 711 acute care providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 16 | $3,014 |
| Prednisone | 209 | $1,097 |
| LantusInsulin Glargine,hum.Rec.Anlog | 11 | $737 |
| Naproxen Sodium | 31 | $643 |
| Methylprednisolone | 74 | $589 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 62 | $554 |
| Azithromycin | 146 | $549 |
| Hydroxyzine Hcl | 19 | $548 |
| Oseltamivir Phosphate | 13 | $479 |
| Pantoprazole Sodium | 34 | $478 |
| Ondansetron OdtOndansetron | 28 | $471 |
| Losartan Potassium | 35 | $389 |
| Dexamethasone | 18 | $384 |
| Atorvastatin Calcium | 32 | $370 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 18 | $349 |
Paid to pharmacies, not to this prescriber.
Other acute care in Dothan
- Rachel PrytulaDothan$14K
- Regan WoodhamDothan$9K
- Paige HarrisMontgomery$465K
- Coretta CollinsBirmingham$77K
- Debra DavisFoley$31K
- Leslie GastonMobile$22K
- Gwendolyn HooperTuscaloosa$16K
- Jennifer UmbargerMobile$14K
- April KlarHuntsville$13K
- Cameron StephensonBirmingham$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.